Target intelligence / Profile preview

NACA pseudogene 8 (NACAP8)

Target
NACAP8
Molecular classification
Other (specifically: Pseudogene / uncharacterized lncRNA pseudogene)
01

Overview

NACA pseudogene 8 (NACAP8) is a human pseudogene listed in genomic databases (e.g., NCBI Gene 101928685, Ensembl ENSG00000257210) and is also known as NACAP3. It is located on chromosome 12 (chr12:93124063-93124543, hg38). There are no known protein products, biological activities, disease associations, or roles as a therapeutic target. The gene is classified as a pseudogene due to its high sequence similarity to the nascent polypeptide-associated complex alpha polypeptide gene but is not believed to encode functional RNA or protein. No experimental studies, clinical uses, or therapeutic development are associated with NACAP8. Importantly, published literature describing pseudogene 8 with clear roles in cancer (as a biomarker or lncRNA therapeutic target) refers to DUXAP8—a totally different gene—rather than NACA pseudogene 8. There is thus a risk of significant misattribution if these two are conflated. Functional and disease information found in cancer and lncRNA literature (DUXAP8) does not apply to NACA pseudogene 8 (NACAP8) but to Double homeobox A pseudogene 8 (DUXAP8), which is distinct and located on a different chromosome. NACA pseudogene 8 is a non-protein-coding genomic sequence with no known clinical or biological significance at this time. If further molecular or therapeutic information is needed about "pseudogene 8" in the context of lncRNAs and cancer, consult the entry for DUXAP8 (“Double homeobox A pseudogene 8”), not NACAP8.

Other names
NACAP3NACA pseudogene 3nascent polypeptide associated complex alpha subunit pseudogene 3nascent-polypeptide-associated complex alpha polypeptide pseudogene 3

Beyond the preview

Go deeper on NACA pseudogene 8 (NACAP8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NACA pseudogene 8 (NACAP8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call